Patents by Inventor Gregor Schutz

Gregor Schutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240407663
    Abstract: Systems, methods, and computer programs disclosed herein relate to training and using a machine learning model to generate contrast-enhanced magnetic resonance images.
    Type: Application
    Filed: October 28, 2022
    Publication date: December 12, 2024
    Inventors: Hubertus PIETSCH, Gregor Jost, Gunnar Schütz, Felix Karl Kreis, Johannes Haubold, René Hosch, Felix Nensa, Michael Forsting
  • Publication number: 20240346718
    Abstract: Disclosed herein are systems and methods for generating artificial contrast-enhanced computed tomography (CT) images. An exemplary computer-implemented method involves receiving representations of an examination region of an examination object after administration of a contrast agent. The representations result from CT examination of the examination region at different X-ray energies. The method involves generating a representation of the contrast agent signals on the basis of the received representations (e.g., a signal intensity distribution brought about by the contrast agent in the examination region). The method involves generating a synthetic representation of the examination region comprising an ?-fold addition of the representation of the contrast agent signals to one of the received representations or to a virtual non-contrast agent representation of the examination region. ? is a negative or positive real number.
    Type: Application
    Filed: April 12, 2024
    Publication date: October 17, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Gregor JOST, Felix Karl KREIS, Johannes HÕHNE, Gunnar SCHÛTZ, Hubertus PIETSCH
  • Patent number: 8501056
    Abstract: The invention relates to a method for the solvent-free preparation of a homogenizate, especially for implants or microparticles, wherein one or more polymers and one or more active constituents, as raw materials, are homogenized together below the glass transition temperature of the polymer(s) and, when homogenization is complete, brought to room temperature.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: August 6, 2013
    Assignee: Hexal AG
    Inventors: Gregor Schütz, Brigitte Freudensprung
  • Patent number: 8084427
    Abstract: The present invention refers to compositions comprising a LH-RH-analogue and/or pharmaceutically acceptable salts thereof in a low-dose and a degradation-resistant polylactide suitable for the preparation of subcutaneous implants. Sterilization of the polylactide via gamma-radiation as well as temperature stress result in a negligible decomposition of less than 1000 Dalton.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: December 27, 2011
    Assignee: Hexel AG
    Inventors: Anna Sendl-Lang, Kai-Thomas Kramer, Gregor Schütz
  • Publication number: 20100168035
    Abstract: The present invention refers to compositions comprising a LH-RH-analogue and/or pharmaceutically acceptable salts thereof in a low-dose and a degradation-resistant polylactide suitable for the preparation of subcutaneous implants. Sterilisation of the polylactide via gamma-radiation as well as temperature stress result in a negligible decomposition of less than 1000 Dalton.
    Type: Application
    Filed: March 20, 2007
    Publication date: July 1, 2010
    Inventors: Anna Sendl-Lang, Kai-Thomas Kramer, Gregor Schütz
  • Publication number: 20040173923
    Abstract: The invention relates to a method for the solvent-free preparation of a homogenisate, especially for implants or microparticles, wherein
    Type: Application
    Filed: May 3, 2004
    Publication date: September 9, 2004
    Inventors: Gregor Schutz, Brigitte Freudensprung